Porton Pharma Solutions Ltd. (SHE:300363)
China · Delayed Price · Currency is CNY 23.24
-0.01 (-0.04%)
Aug 28, 2025, 9:45 AM CST
Porton Pharma Solutions Company Description
Porton Pharma Solutions Ltd. provides contract development and manufacturing organization (CDMO) solutions for small molecules, tides, biologics, and conjugates from pre-clinical to commercial.
It has a strategic collaboration with Aojin Life Sciences to advance XDC conjugate drugs; and strategic partnership with Porton Pharma Solutions and Dragon Sail Pharmaceutical to build a new ecosystem for ADC drug development, production, and supply chain.
The company operates in China and internationally. The company was formerly known as Porton Fine Chemicals Ltd. and changed its name to Porton Pharma Solutions Ltd. in January 2018.
Porton Pharma Solutions Ltd. was incorporated in 2005 and is headquartered in Chongqing, China.
Porton Pharma Solutions Ltd.
| Country | China |
| Founded | 2005 |
| Industry | Drug Manufacturers - Specialty & Generic |
| Sector | Healthcare |
| Employees | 4,214 |
| CEO | Nianfeng Ju |
Contact Details
Address: No.7, Yuntu Road Chongqing, 400714 China | |
| Phone | 86 23 6593 6900 |
| Website | portonpharma.com |
Stock Details
| Ticker Symbol | 300363 |
| Exchange | Shenzhen Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100001S57 |
| SIC Code | 2833 |
Key Executives
| Name | Position |
|---|---|
| Nianfeng Ju | Chairman and GM |
| Hui Chen | Deputy GM and Chief Financial Officer |
| Yinchun Bai | Senior Deputy GM and Chief Operating Officer |
| Wei Pi | Deputy GM and Secretary of the Board of Directors |
| Po Zhu | Deputy General Manager |
| Qi Chen | Deputy General Manager |